Product Information
AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK) is a brand product labeled by Teva Pharmaceuticals USA Inc., priced at $507.4470 per ML under NDC 51759020222. Its NADAC has been published 257 times since Feb 17, 2021.
Strength
225 mg/1.5mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
51759020222
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
FREMANEZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761089On Market Since
3/29/2020
Price Statistics
The NADAC for AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK) has been published 257 times since Feb 17, 2021, and over the history we have for it it has risen 24.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $507.4470 per ML |
|---|---|
| All-time high | $508.5571 (Jul 15, 2026) |
| All-time low | $408.4535 (Feb 17, 2021) |
| 52-week high | $508.5571 |
| 52-week low | $482.1698 |
| Median price | $470.7796 |
| Average price | $463.3148 |
| Largest weekly change | +5.0% (Jan 3, 2024) |
| Weeks tracked | 257 |
| Tracking since | Feb 17, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fremanezumab-vfrm market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK)?
The current National Average Drug Acquisition Cost (NADAC) for AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK), manufactured by Teva Pharmaceuticals USA Inc., is $507.4470 per ML (NDC 51759020222), effective Sep 30, 2026.
How has the price of AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK) changed over time?
Over the history we have for it, the NADAC for AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK) has risen 24.2%. It has been tracked across 257 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK)?
Since Feb 17, 2021, the NADAC for AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK) has ranged from a low of $408.4535 (Feb 17, 2021) to a high of $508.5571 (Jul 15, 2026), with a median of $470.7796 per ML.
Are there cheaper alternatives to AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK)?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK) in a comparable dosage form, but none are currently priced below it.
Who manufactures AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK)?
AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK) (NDC 51759020222) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a brand product.